Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of MS Care|April 21, 2015
A randomized placebo-controlled trial of duloxetine for central pain in multiple sclerosisTheodore R Brown, April Slee
International Journal of MS Care|July 2, 2020
A Topical Adhesive Containing Anesthetic and Heating Components to Reduce Injection Pain with Subcutaneous Multiple Sclerosis Medications: A Pilot StudyTheodore R Brown, Virginia I Simnad
International Journal of MS Care|August 24, 2016
A Randomized Crossover Trial of Dalfampridine Extended Release for Effect on Ambulatory Activity in People with Multiple SclerosisTheodore R Brown, Virginia I Simnad
Physical Medicine and Rehabilitation Clinics of North America|May 17, 2005
Exercise and rehabilitation for individuals with multiple sclerosisTheodore R Brown, George H Kraft
International Journal of MS Care|October 23, 2014
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosisAndrew D Goodman, Theodore R Brown, Randall T Schapiro, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2015
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trialsAndrew D Goodman, Francois Bethoux, Theodore R Brown, et al.
American Journal of Public Health|October 17, 2008
Past trends and current status of self-reported incidence and impact of disease and nonbattle injury in military operations in Southwest Asia and the Middle EastMark S Riddle, David R Tribble, Shannon D Putnam, et al.
Lancet (London, England)|March 3, 2009
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trialAndrew D Goodman, Theodore R Brown, Lauren B Krupp, et al.
Annals of Neurology|October 27, 2010
A phase 3 trial of extended release oral dalfampridine in multiple sclerosisAndrew D Goodman, Theodore R Brown, Keith R Edwards, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 26, 2018
Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trialJeffrey A Cohen, Samuel F Hunter, Theodore R Brown, et al.
Pageof 2